Gavi commits USD 1.65 billion for COVID vaccines though demand is ‘close to zero’

The vaccine alliance Gavi will hold onto 60 per cent of the USD 2.7 billion that remain unspent in COVAX to purchase more COVID-19 vaccines, even though demand is low, and most deliveries are currently covered by donations. This leaves Gavi with USD 1 billion in unspent COVID funds. The agency is exploring three options for spending this remaining money.